Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MBOT - US59503A2042 - Common Stock

2.09 USD
-0.1 (-4.57%)
Last: 1/9/2026, 8:01:31 PM
2.09 USD
0 (0%)
After Hours: 1/9/2026, 8:01:31 PM
Fundamental Rating

3

Overall MBOT gets a fundamental rating of 3 out of 10. We evaluated MBOT against 185 industry peers in the Health Care Equipment & Supplies industry. While MBOT has a great health rating, there are worries on its profitability. MBOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MBOT has reported negative net income.
In the past year MBOT has reported a negative cash flow from operations.
In the past 5 years MBOT always reported negative net income.
In the past 5 years MBOT always reported negative operating cash flow.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of MBOT (-15.99%) is comparable to the rest of the industry.
MBOT has a Return On Equity of -16.71%. This is in the better half of the industry: MBOT outperforms 62.16% of its industry peers.
Industry RankSector Rank
ROA -15.99%
ROE -16.71%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MBOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

MBOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MBOT has been increased compared to 5 years ago.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 23.81 indicates that MBOT is not in any danger for bankruptcy at the moment.
MBOT has a Altman-Z score of 23.81. This is amongst the best in the industry. MBOT outperforms 95.68% of its industry peers.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.81
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

MBOT has a Current Ratio of 27.53. This indicates that MBOT is financially healthy and has no problem in meeting its short term obligations.
MBOT's Current ratio of 27.53 is amongst the best of the industry. MBOT outperforms 98.92% of its industry peers.
A Quick Ratio of 27.53 indicates that MBOT has no problem at all paying its short term obligations.
The Quick ratio of MBOT (27.53) is better than 98.92% of its industry peers.
Industry RankSector Rank
Current Ratio 27.53
Quick Ratio 27.53
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

MBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.21%, which is quite impressive.
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

MBOT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.61% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.96%
EPS Next 2Y23.75%
EPS Next 3Y15.61%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2025 2026 2027 2M 4M 6M 8M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MBOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

MBOT's earnings are expected to grow with 15.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.75%
EPS Next 3Y15.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MBOT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (1/9/2026, 8:01:31 PM)

After market: 2.09 0 (0%)

2.09

-0.1 (-4.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners13.84%
Inst Owner Change0%
Ins Owners1.47%
Ins Owner Change0%
Market Cap140.36M
Revenue(TTM)N/A
Net Income(TTM)-13.07M
Analysts82.86
Price Target7.65 (266.03%)
Short Float %9.56%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.46%
Min EPS beat(2)-22.55%
Max EPS beat(2)-14.38%
EPS beat(4)1
Avg EPS beat(4)-3.43%
Min EPS beat(4)-22.55%
Max EPS beat(4)32.13%
EPS beat(8)4
Avg EPS beat(8)1.02%
EPS beat(12)8
Avg EPS beat(12)6.9%
EPS beat(16)9
Avg EPS beat(16)2.11%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.5%
PT rev (3m)-37.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.75%
EPS NY rev (1m)1.61%
EPS NY rev (3m)10.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-85%
Revenue NY rev (1m)-50%
Revenue NY rev (3m)-90.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.99%
ROE -16.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 27.53
Quick Ratio 27.53
Altman-Z 23.81
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
EPS Next Y57.96%
EPS Next 2Y23.75%
EPS Next 3Y15.61%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.68%
EBIT Next 3Y-26.74%
EBIT Next 5YN/A
FCF growth 1Y-19.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.73%
OCF growth 3YN/A
OCF growth 5YN/A

MICROBOT MEDICAL INC / MBOT FAQ

What is the ChartMill fundamental rating of MICROBOT MEDICAL INC (MBOT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MBOT.


Can you provide the valuation status for MICROBOT MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to MICROBOT MEDICAL INC (MBOT). This can be considered as Overvalued.


How profitable is MICROBOT MEDICAL INC (MBOT) stock?

MICROBOT MEDICAL INC (MBOT) has a profitability rating of 1 / 10.


What is the financial health of MICROBOT MEDICAL INC (MBOT) stock?

The financial health rating of MICROBOT MEDICAL INC (MBOT) is 8 / 10.